Hikma Pharmaceuticals PLC (HIK) — Cash Flow-to-Debt Ratio
Hikma Pharmaceuticals PLC (HIK) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2025, meaning its operating cash flow of GBX161.00 Million could theoretically repay 0% of its total liabilities (GBX3.00 Billion) in one year. See cash generation quality of Hikma Pharmaceuticals PLC to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hikma Pharmaceuticals PLC Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Hikma Pharmaceuticals PLC across 23 annual periods. Also explore HIK shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year debt coverage analysis for Hikma Pharmaceuticals PLC. For market capitalisation and broader financial context, see HIK stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | GBX564.00 Million | GBX2.81 Billion | ▼ -18.5% |
| 2023 | 0.25x | GBX608.00 Million | GBX2.47 Billion | ▲ +7.8% |
| 2022 | 0.23x | GBX530.00 Million | GBX2.32 Billion | ▼ -31.9% |
| 2021 | 0.33x | GBX638.00 Million | GBX1.91 Billion | ▲ +43.4% |
| 2020 | 0.23x | GBX464.00 Million | GBX1.99 Billion | ▼ -10.9% |
| 2019 | 0.26x | GBX472.00 Million | GBX1.80 Billion | ▲ +9.7% |
| 2018 | 0.24x | GBX430.00 Million | GBX1.80 Billion | ▲ +0.3% |
| 2017 | 0.24x | GBX443.00 Million | GBX1.86 Billion | ▲ +58.7% |
| 2016 | 0.15x | GBX293.00 Million | GBX1.95 Billion | ▼ -48.9% |
| 2015 | 0.29x | GBX366.00 Million | GBX1.25 Billion | ▼ -28.4% |
| 2014 | 0.41x | GBX425.00 Million | GBX1.03 Billion | ▲ +9.1% |
| 2013 | 0.38x | GBX337.00 Million | GBX895.00 Million | ▲ +82.4% |
| 2012 | 0.21x | GBX182.16 Million | GBX882.26 Million | ▲ +56.3% |
| 2011 | 0.13x | GBX102.64 Million | GBX777.01 Million | ▼ -65.2% |
| 2010 | 0.38x | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.31x | GBX105.52 Million | GBX339.46 Million | ▲ +92.0% |
| 2008 | 0.16x | GBX57.87 Million | GBX357.46 Million | ▲ +76.2% |
| 2007 | 0.09x | GBX43.12 Million | GBX469.38 Million | ▼ -57.6% |
| 2006 | 0.22x | GBX29.99 Million | GBX138.56 Million | ▼ -26.9% |
| 2005 | 0.30x | GBX32.71 Million | GBX110.48 Million | ▼ -8.7% |
| 2004 | 0.32x | GBX32.84 Million | GBX101.31 Million | ▲ +1.4% |
| 2003 | 0.32x | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX46.84 Million | — |